Drug Type Unknown |
Synonyms- |
Target |
Action inhibitors |
Mechanism UBE2D1 inhibitors(ubiquitin conjugating enzyme E2 D1 inhibitors), Ubiquitin conjugating enzyme E2 inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neurodegenerative Diseases | Preclinical | United States | 01 Dec 2025 |





